Showing results (51-60 of 57) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Plos Genetics|December 3, 2010
Conserved genes act as modifiers of invertebrate SMN loss of function defectsMaria Dimitriadi, James N Sleigh, Amy Walker, et al.Neuro-Oncology|March 18, 2009
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant gliomaJennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant gliomaJennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.Journal for Immunotherapy of Cancer|May 13, 2026
Synthetic DNA vaccine platform elicits potent immunity where electroporated naked-mRNA is non-immunogenicClaudia Tonini, Andrea Bianchi, Mauro Esposito, et al.Journal of Perinatology : Official Journal of the California Perinatal Association|July 18, 2020
A quality improvement initiative to implement the eat, sleep, console neonatal opioid withdrawal syndrome care tool in Massachusetts' PNQIN collaborativeElisha M Wachman, Mary Houghton, Patrice Melvin, et al.Neuro-Oncology|May 12, 2004
Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant gliomaJennifer A Quinn, David A Reardon, Allan H Friedman, et al.Neuro-Oncology|May 12, 2004
Phase 2 trial of BCNU plus irinotecan in adults with malignant gliomaDavid A Reardon, Jennifer A Quinn, Jeremy N Rich, et al.Pageof 6